Funds support local vaccine-making

Vietnam and other countries are in line to get their own vaccine manufacturing capabilities, thanks to PATH, the Program for Appropriate Technology in Health. The international nonprofit is receiving $8 million from HHS's Biomedical Advanced Research and Development Authority to assist in the production and clinical development of influenza vaccines, a step toward building local production capacity in developing countries. Article

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.